GAITHERSBURG, Md., Oct. 22, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its VP Artificial Intelligence, Enrique García-Rivera, Ph.D., will present at Google’s inaugural Cancer AI Symposium on...Read more
NASHVILLE, Tenn. / Oct 21, 2024 / Business Wire / HealthStream, Inc. (the “Company”) (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the third quarter ended September 30, 2024. Third Quarter 2024 Revenues of $73.1 million in the third quarter of 2024, up 3.9% from $70.3 million in the third quarter of 2023 Operating income of $6.5 million in the third quarter of 2024, up...Read more
New Director Brings Deep Financial and Operational Expertise MOBILE, Ala. / Oct 21, 2024 / Business Wire / TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ:TBRG), a healthcare solutions company, today announced the election of Amy O’Keefe to its Board of Directors (the “Board”), effective October 18, 2024. O’Keefe currently serves as Chief Financial Officer of Avaya, a contact center and communications solutions provider backed...Read more
Application goes beyond data aggregation to help clinicians quickly see a longitudinal view of their patient’s history, spotlighting disease progression and helping to inform proactive interventions Tampa General Hospital and UT Southwestern Medical Center to be early evaluators of CareIntellect for Oncology Application is the first within GE HealthCare’s new CareIntellect offering of clinical and operational applications, built to...Read more
Innovations include Health Companion research project powered by agentic AI Additional early innovations explore pressing care needs, including identifying new ways to detect breast cancer and improving quality of care for moms and babies CHICAGO / Oct 21, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company....Read more
GAITHERSBURG, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today it has closed its previously announced definitive agreement for the purchase and sale of an aggregate of 1,565,000...Read more
Participating in-person at the LD Micro Main Event XVII from October 28-30th at the Luxe Sunset Boulevard Hotel in Los Angeles Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL, will be participating...Read more
GE HealthCare announces Hospital Pulse, the newest tile for its Command Center Software Platform CHICAGO / Oct 17, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a new tile for its Command Center Software: Hospital Pulse. Hospital Pulse Tile pulls in real-time information from across departments to quickly surface the most vital information about a healthcare system’s operations in a customizable dashboard designed...Read more
Bringing together leading global healthcare innovator and European healthcare institutions, this relationship aims to advance Theranostics in clinical practice and the development of new tracers and technologies for more personalized medicine Theranostics is a transformative approach to cancer treatment, giving hope to patients and their loved ones and the potential for an improved quality of life The practice of Theranostics is...Read more
Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO / Oct 16, 2024 / Business Wire / GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be able to use Affirm to pay over time for select medications at participating retail pharmacies. This adds a convenient way for consumers to pay for their...Read more
PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to democratize access to single cell analysis. The new offerings – GEM-X Flex and GEM-X Universal Multiplex – introduce significant improvements in performance, workflow and cost effectiveness, enabling more researchers to pursue single cell...Read more
DRAPER, Utah, Oct. 15, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity") in celebration of National HSA Awareness Day, has launched HSAnswers. Powered by a comprehensive and bespoke database of resources, research, and insights, the free-to-use AI chat tool can help individuals obtain clear answers to questions about HSAs and other consumer-directed benefits. In 2024 HealthEquity surveyed over 600 employees who...Read more
Versana Premier is designed to feel familiar from day one, simplifying workflow and making it easier for clinicians in multiple-purpose practices to deliver high-quality care to a wide range of patient populations and care scenarios Powered by VisionBoost Architecture, Versana Premier offers an advanced imaging platform designed to deliver exceptional image quality with its next generation image engine, first-class display technology,...Read more
Vancouver, British Columbia--(Newsfile Corp. - October 11, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) ("Kovo" or the "Company") is pleased to announce that it has closed its previously announced asset purchase agreement (the "APA") with HEAL USA, Inc. ("HEAL"), whereby the Company acquired the exclusive right to purchase certain contractual assets of Coredynamex, LLC, the Utah limited liability company (doing business as "AccelVue")...Read more
FRAMINGHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of Market Forecast, a powerful predictive analytics solution designed to help healthcare organizations uncover high-growth markets and service line opportunities to strengthen investments and partnerships. Delivering year-over-year growth rate and market demand projections up...Read more
PLEASANTON, Calif., Oct. 9, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary select results for the third quarter ended September 30, 2024. Preliminary Select Third Quarter 2024 Results Revenue of approximately $151.7 million for the third quarter ended September 30, 2024, representing an approximate 1% decrease from the corresponding prior year...Read more
Integrated feature from Blackford offers AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity CHICAGO / Oct 09, 2024 / Business Wire / GE HealthCare integrates third party artificial intelligence (AI)-enabled application orchestration feature into True PACS and Centricity PACS. 1 In collaboration with Blackford, the new AI-enabled offerings help radiologists with their workload which...Read more
The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCC The findings suggest that targeting β2-spectrin with BF-114 can prevent the progression of liver diseases New data builds on earlier studies and further supports BF-114’s potential to address major unmet needs in treating obesity-related liver diseases Dr. Lopa...Read more
NEW YORK / Oct 09, 2024 / Business Wire / Schrödinger (Nasdaq: SDGR) today announced that new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, and the company’s PRMT5-MTA inhibitor program, will be presented during poster sessions at the 36th EORTC-NCI-AACR Symposium (ENA 2024) taking place October 23-25, 2024 in Barcelona, Spain. The SGR-3515 presentation will include data further characterizing SGR-3515 in...Read more
Data to be presented at the International Conference on Newborn Sequencing (ICoNS) highlighting lessons learned from the GUARDIAN and Early Check newborn sequencing studies showcasing GeneDx’s deep expertise as the leader for gNBS STAMFORD, Conn. / Oct 08, 2024 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it has provided genomic newborn screenings...Read more
Atlanta, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has debuted a new quality module for eValuator and successfully implemented that module at an existing eValuator client. Streamline Health is leading an industry movement to improve hospital financial performance through...Read more
BOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Hello Heart, the digital leader in preventive heart health, is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform. Amwell health plan clients can now offer their employer accounts the Hello Heart cardiovascular solution to eligible members and employees with high...Read more
SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024. “As we enter the second half of fiscal year 2025, we are well positioned to deliver our first full year of Adjusted EBITDA profitability and positive cash flow. Accolade is proving the scalability and profitability of a business model and strategy that is fundamentally designed to...Read more
CHICAGO / Oct 07, 2024 / Business Wire / GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. The €25.3 million project gathers 29 partners from top European academic and clinical sites, small and medium-sized enterprises, and patient advocacy groups. Cancer is the leading cause of death worldwide,...Read more
Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well tolerated with no serious adverse events, dose-limiting toxicities or clinically relevant findings reported. If approved, this agent could provide an alternative to gadolinium-based contrast agents and address the potential impact of post-patient...Read more
Curren Katz Named Senior Vice President, Chief Data Science Officer Tara O’Neil Promoted to General Counsel; Scott Mays Promoted to SVP, Legal and Deputy General Counsel NEW YORK / Oct 03, 2024 / Business Wire / MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare...Read more
Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, announces the release of its latest innovation, “TRIM,” a compounded, oral dissolvable Tirzepatide tablet. Available for purchase at $399 per month, this new product offers patients an advanced and...Read more
NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, today announced its participation in the 72nd edition of the Journées Francophones de Radiologie (JFR) 2024 Meeting, taking place from October 4-7 in Paris, France. At JFR, iCAD will premier ProFound Cloud, a secure, scalable SaaS platform designed to...Read more
Toronto, Ontario--(Newsfile Corp. - October 2, 2024) - NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) (FSE: 8TV) (the "Company" or "NetraMark") a generative AI software leader in clinical trial analytics, is pleased to announce its participation at the upcoming Cantech Letter Conference on Wednesday, October 9, 2024 in Toronto Ontario. George Achilleos, CEO of NetraMark, will be delivering a corporate presentation, where he will...Read more
MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the weight loss category Dallas, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, proudly announces that its highly anticipated oral...Read more
ALL-REMOTE COMPANY/WILMINGTON, Del. / Oct 01, 2024 / Business Wire / Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that its contract with the CMS Innovation Center (CMMI) for use of the Patient Activation Measure® (PAM) has been renewed through 2029. The PAM performance measure, which assesses gains in patients’ knowledge, skills and confidence in managing their own healthcare, is one of the first...Read more
Vancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) ("Kovo" or the "Company") is pleased to announce that it has entered into an asset purchase agreement dated September 30, 2024 (the "Asset Purchase Agreement") with HEAL USA, Inc. ("HEAL USA") pursuant to which the Company will acquire from HEAL USA the exclusive right to purchase certain contractual assets of Coredynamex, LLC,...Read more
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, the predominant procedure used in nuclear cardiology today With a half-life over ten times longer than currently approved cardiac PET radiotracers, Flyrcado brings the first practical opportunity to combine exercise stress testing with...Read more
Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can Clarify MC Etiology and Help Stratify MC Patients to Potentially Inform Better Treatment Decisions for cLBP Patients Results Presented at the 50th International Society for the Study of the Lumbar Spine (ISSLS) Annual Meeting 2024 BROOMFIELD,...Read more
CHICAGO / Sep 26, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the American Society for Radiation Oncology (ASTRO) 2024 conference in Washington, DC. These novel solutions aim to improve the entirety of the radiation therapy workflow for clinicians and cancer patients. It is estimated that 470,000 patients receive radiotherapy each year in the...Read more
MINNEAPOLIS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into a securities purchase agreement with an affiliate of Off the Chain Capital (collectively, “Off the Chain”) in a follow-on...Read more
HEALWELL AI CEO, Dr. Alexander Dobranowski, to present live at 10:00 AM PT on Wednesday, October 9, 2024 Vancouver, British Columbia--(Newsfile Corp. - September 25, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024 in...Read more
The Company taps business and operations executive with expertise that spans healthcare and med tech to help scale pharmacy automation and drive multi-year innovation and excellence FORT WORTH, Texas / Sep 25, 2024 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that Nnamdi Njoku has been appointed Executive Vice President and...Read more
Leading health systems and providers experience increased productivity, revenue, and satisfaction with AI adoption 75% report positive ROI from AI in healthcare payments; 90% plan to boost AI investments in the near future LEHI, Utah and LOUISVILLE, Ky., Sept. 24, 2024 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, and Modern Healthcare today announced new research that...Read more
TORONTO, Sept. 24, 2024 /CNW/ - Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled habit change provider focused on preventing, slowing, and reversing metabolic disease, is pleased to announce a new Framework Agreement with a supplemental insurance payvider ("Payvider") to offer its proven habit change platform to thousands of U.S. workers as a fully-covered benefit starting in 2025. This...Read more
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE